DK2809343T3 - Fremgangsmåde til fermentering - Google Patents

Fremgangsmåde til fermentering

Info

Publication number
DK2809343T3
DK2809343T3 DK13701484.1T DK13701484T DK2809343T3 DK 2809343 T3 DK2809343 T3 DK 2809343T3 DK 13701484 T DK13701484 T DK 13701484T DK 2809343 T3 DK2809343 T3 DK 2809343T3
Authority
DK
Denmark
Prior art keywords
fermentation
Prior art date
Application number
DK13701484.1T
Other languages
English (en)
Inventor
Philippe Marc Helene Dehottay
Philippe Goffin
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Application granted granted Critical
Publication of DK2809343T3 publication Critical patent/DK2809343T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK13701484.1T 2012-02-01 2013-01-30 Fremgangsmåde til fermentering DK2809343T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261593541P 2012-02-01 2012-02-01
PCT/EP2013/051743 WO2013113729A1 (en) 2012-02-01 2013-01-30 Fermentation process

Publications (1)

Publication Number Publication Date
DK2809343T3 true DK2809343T3 (da) 2017-11-27

Family

ID=47605571

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13701484.1T DK2809343T3 (da) 2012-02-01 2013-01-30 Fremgangsmåde til fermentering

Country Status (17)

Country Link
US (1) US9475848B2 (da)
EP (1) EP2809343B1 (da)
JP (2) JP6181082B2 (da)
CN (1) CN104093416B (da)
BR (1) BR112014017898B1 (da)
CA (1) CA2862560A1 (da)
CY (1) CY1119902T1 (da)
DK (1) DK2809343T3 (da)
ES (1) ES2653261T3 (da)
HR (1) HRP20171826T1 (da)
HU (1) HUE037681T2 (da)
LT (1) LT2809343T (da)
NO (1) NO2825725T3 (da)
PL (1) PL2809343T3 (da)
PT (1) PT2809343T (da)
SI (1) SI2809343T1 (da)
WO (1) WO2013113729A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201316351D0 (da) * 2013-09-13 2013-10-30 Glaxosmithkline Biolog Sa
CN104263678A (zh) * 2014-09-02 2015-01-07 成都欧林生物科技股份有限公司 一种白喉杆菌培养基及应用其制备白喉类毒素的方法
CN104263687A (zh) * 2014-09-29 2015-01-07 成都欧林生物科技股份有限公司 一种百日咳杆菌的无动物源培养基及其培养方法
EP3699263A1 (en) 2019-02-22 2020-08-26 GlaxoSmithKline Biologicals S.A. Fermentation process
CN113151081A (zh) * 2021-04-21 2021-07-23 深圳市儿童医院 一种百日咳鲍特菌培养基及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59184132A (ja) * 1983-04-02 1984-10-19 Chemo Sero Therapeut Res Inst 百日ぜきワクチンの製造方法
JPS59181222A (ja) * 1983-03-30 1984-10-15 Chemo Sero Therapeut Res Inst 百日ぜき菌の感染防御抗原ｈａ画分の製造方法
CA1213234A (en) * 1983-03-30 1986-10-28 Akihiro Ginnaga Method for the production of ha fraction containing protective antigens of bordetella pertussis and pertussis vaccine
EP0427462B1 (en) 1989-11-06 1996-02-14 SMITHKLINE BEECHAM BIOLOGICALS (S.A.), formerly SMITHKLINE BIOLOGICALS (S.A.) Process
ATE129159T1 (de) 1990-02-12 1995-11-15 Smithkline Beecham Biolog Impfstoff.
FI945483A7 (fi) 1992-05-23 1995-01-20 Smithkline Beecham Biologicals S A Hepatiitti B - pinta-antigeenejä ja muita antigeenejä sisältäviä yhdistelmärokotteita
CA2138178A1 (en) 1993-12-22 1995-06-23 Andrew Herbert Control of ph during bordetella growth
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
PL184872B1 (pl) 1995-06-23 2003-01-31 Smithkline Beecham Biolog Kombinowana szczepionkaĆ zestaw do przygotowania kombinowanej szczepionkiĆ sposób wytwarzania kombinowanej szczepionki i jej zastosowanie
EP1268531B1 (en) * 2000-04-04 2005-07-06 Baxter International Inc. Method for the production of bacterial toxins

Also Published As

Publication number Publication date
LT2809343T (lt) 2017-12-11
HUE037681T2 (hu) 2018-09-28
JP2015506691A (ja) 2015-03-05
BR112014017898A2 (da) 2017-06-20
US9475848B2 (en) 2016-10-25
JP6181082B2 (ja) 2017-08-16
CN104093416A (zh) 2014-10-08
PT2809343T (pt) 2017-12-21
ES2653261T3 (es) 2018-02-06
JP6582020B2 (ja) 2019-09-25
WO2013113729A1 (en) 2013-08-08
SI2809343T1 (en) 2018-01-31
EP2809343B1 (en) 2017-10-04
NO2825725T3 (da) 2018-07-28
EP2809343A1 (en) 2014-12-10
CA2862560A1 (en) 2013-08-08
US20150010948A1 (en) 2015-01-08
PL2809343T3 (pl) 2018-03-30
HRP20171826T1 (hr) 2017-12-29
CY1119902T1 (el) 2018-06-27
BR112014017898B1 (pt) 2021-10-13
CN104093416B (zh) 2016-10-19
BR112014017898A8 (pt) 2017-07-11
JP2018007676A (ja) 2018-01-18

Similar Documents

Publication Publication Date Title
BR112015013188A2 (pt) método de fermentação otimizado
EP2929038A4 (en) fermentation
DK2914965T3 (da) Aflukker til biologiske mikroobjekter
DK2904088T3 (da) Gas-tilført fermentationssystem
HUE060718T4 (hu) Glikokonjugációs eljárás
DK3777840T3 (da) Rna-formulering til immunterapi
DK3004366T3 (da) Mikroorganismer til diterpenproduktion
FI20125613L (fi) Menetelmä ligniinin fraktioimiseksi
DK2649029T3 (da) Fremgangsmåde til depolymerisering
CU24158B1 (es) Método de obtención de 1-kestosa
FI20125708L (fi) Prosessi hiilivetyjen valmistamiseksi
DK2800476T3 (da) Fremgangsmåde til fodring
DK2849760T3 (da) Fremgangsmåder til oligonukleotid-chelatkompleks
EP2831249A4 (en) FERMENTATION PROCESSES
IL238507A0 (en) Butadiene extraction process
CO6831990A2 (es) Proceso de tableta de caldo
EP2880048A4 (en) METHOD
EP2925874A4 (en) fermentation
FR2998290B1 (fr) Procede de potabilisation
EP2920316A4 (en) fermentation
HUE046547T2 (hu) Eljárás biomassza extrahálására
FR2995231B1 (fr) Procede de trefilage
DK2476534T3 (da) Fremgangsmåde til formning
DK2809343T3 (da) Fremgangsmåde til fermentering
DK2888591T3 (da) Fremgangsmåde til forbedret celleidentifikation